Theodore Karrison

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

Lalitha Iyer, Soma Das, Linda Janisch et al. · The Pharmacogenomics Journal · 2002 · 711 citations

Irinotecan Disposition, Medicine, Genetics +5

Methylnaltrexone for Reversal of Constipation Due to Chronic Methadone Use

Chun‐Su Yuan, Joseph Foss, Michael O’Connor et al. · JAMA · 2000 · 297 citations

Pharmacogenomic and Pharmacokinetic Determinants of Erlotinib Toxicity

Charles M. Rudin, Wanqing Liu, Apurva A. Desai et al. · Journal of Clinical Oncology · 2008 · 217 citations · Full text

Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma

Daniel J. Olson, Zeynep Eroglu, Bruce Brockstein et al. · Journal of Clinical Oncology · 2021 · 214 citations · Full text

Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.

Ralph R. Weichselbaum, William K. Dahlberg, M A Beckett et al. · Proceedings of the National Academy of Sciences · 1986 · 174 citations · Full text

Radiation Effect, Radiation Exposure, Radiation Biology +23